APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biopharmaceutical CRO

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Biopharmaceutical CRO Market Analysis and Forecast 2026-2032

3 May 2026223 pages

Choose your research edition.

Industry ResearchBiopharmaceutical CRO Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Biopharmaceutical CRO Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Biopharmaceutical CRO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biopharmaceutical CRO Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Biopharmaceutical CRO Market Analysis and Forecast 2026-2032223 pages · $4,950 USD

Market perspective

The global Biopharmaceutical CRO market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Biopharmaceutical CRO is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Biopharmaceutical CRO is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Biopharmaceutical CRO is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Biopharmaceutical CRO is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Biopharmaceutical CRO include WuXi AppTec, WuXi Biologics, Hangzhou Tigermed, Pharmaron Beijing, ICON, PPD, BioPharma Services, TriStar Technology Group and Fortrea, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Biopharmaceutical CRO, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Biopharmaceutical CRO, also provides the revenue of main regions and countries. Of the upcoming market potential for Biopharmaceutical CRO, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biopharmaceutical CRO revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biopharmaceutical CRO market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Biopharmaceutical CRO revenue, projected growth trends, production technology, application and end-user industry.

Biopharmaceutical CRO Segment by Company

WuXi AppTec

WuXi Biologics

Hangzhou Tigermed

Pharmaron Beijing

ICON

PPD

BioPharma Services

TriStar Technology Group

Fortrea

Eurofins BioPharma Services

Medicilon

Asymchem

UBC

SanaClis

TFS HealthScience

Parexel

Biopharmaceutical CRO Segment by Type

Full-service CRO

Specialized CRO

Biopharmaceutical CRO Segment by Application

SMBs

Large Enterprises

Biopharmaceutical CRO Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopharmaceutical CRO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biopharmaceutical CRO and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopharmaceutical CRO.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Biopharmaceutical CRO in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Biopharmaceutical CRO company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biopharmaceutical CRO revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biopharmaceutical CRO Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Full-service CRO Major Player Table 3. Specialized CRO Major Player Table 4. Global Biopharmaceutical CRO Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. SMBs Major Player Table 6. Large Enterprises Major Player Table 7. Biopharmaceutical CRO Industry Trends Table 8. Biopharmaceutical CRO Industry Drivers Table 9. Biopharmaceutical CRO Industry Opportunities and Challenges Table 10. Biopharmaceutical CRO Industry Restraints Table 11. Global Biopharmaceutical CRO Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Biopharmaceutical CRO Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Biopharmaceutical CRO Market Share by Region (2021-2026) Table 14. Global Biopharmaceutical CRO Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Biopharmaceutical CRO Market Share by Region (2027-2032) Table 16. Global Biopharmaceutical CRO Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Biopharmaceutical CRO Revenue Market Share by Players (2021-2026) Table 18. Global Biopharmaceutical CRO Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Biopharmaceutical CRO Key Players Headquarters & Area Served Table 20. Global Biopharmaceutical CRO Players, Product Type & Application Table 21. Global Biopharmaceutical CRO Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Biopharmaceutical CRO by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Biopharmaceutical CRO Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Biopharmaceutical CRO Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Biopharmaceutical CRO Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Biopharmaceutical CRO Revenue Market Share by Type (2021-2026) Table 28. Global Biopharmaceutical CRO Revenue Market Share by Type (2027-2032) Table 29. Global Biopharmaceutical CRO Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Biopharmaceutical CRO Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Biopharmaceutical CRO Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Biopharmaceutical CRO Revenue Market Share by Application (2021-2026) Table 33. Global Biopharmaceutical CRO Revenue Market Share by Application (2027-2032) Table 34. WuXi AppTec Company Information Table 35. WuXi AppTec Business Overview Table 36. WuXi AppTec Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. WuXi AppTec Biopharmaceutical CRO Product Portfolio Table 38. WuXi AppTec Recent Development Table 39. WuXi Biologics Company Information Table 40. WuXi Biologics Business Overview Table 41. WuXi Biologics Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. WuXi Biologics Biopharmaceutical CRO Product Portfolio Table 43. WuXi Biologics Recent Development Table 44. Hangzhou Tigermed Company Information Table 45. Hangzhou Tigermed Business Overview Table 46. Hangzhou Tigermed Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Hangzhou Tigermed Biopharmaceutical CRO Product Portfolio Table 48. Hangzhou Tigermed Recent Development Table 49. Pharmaron Beijing Company Information Table 50. Pharmaron Beijing Business Overview Table 51. Pharmaron Beijing Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Pharmaron Beijing Biopharmaceutical CRO Product Portfolio Table 53. Pharmaron Beijing Recent Development Table 54. ICON Company Information Table 55. ICON Business Overview Table 56. ICON Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. ICON Biopharmaceutical CRO Product Portfolio Table 58. ICON Recent Development Table 59. PPD Company Information Table 60. PPD Business Overview Table 61. PPD Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. PPD Biopharmaceutical CRO Product Portfolio Table 63. PPD Recent Development Table 64. BioPharma Services Company Information Table 65. BioPharma Services Business Overview Table 66. BioPharma Services Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. BioPharma Services Biopharmaceutical CRO Product Portfolio Table 68. BioPharma Services Recent Development Table 69. TriStar Technology Group Company Information Table 70. TriStar Technology Group Business Overview Table 71. TriStar Technology Group Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. TriStar Technology Group Biopharmaceutical CRO Product Portfolio Table 73. TriStar Technology Group Recent Development Table 74. Fortrea Company Information Table 75. Fortrea Business Overview Table 76. Fortrea Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Fortrea Biopharmaceutical CRO Product Portfolio Table 78. Fortrea Recent Development Table 79. Eurofins BioPharma Services Company Information Table 80. Eurofins BioPharma Services Business Overview Table 81. Eurofins BioPharma Services Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Eurofins BioPharma Services Biopharmaceutical CRO Product Portfolio Table 83. Eurofins BioPharma Services Recent Development Table 84. Medicilon Company Information Table 85. Medicilon Business Overview Table 86. Medicilon Biopharmaceutical CRO Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Medicilon Biopharmaceutical CRO Product Portfolio Table 88. Medicilon Recent Development Table 89. Asymchem Company Information Table 90. Asymchem Business Overview Table 91. Asymchem Biopharmaceutical CRO Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Asymchem Biopharmaceutical CRO Product Portfolio Table 93. Asymchem Recent Development Table 94. UBC Company Information Table 95. UBC Business Overview Table 96. UBC Biopharmaceutical CRO Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. UBC Biopharmaceutical CRO Product Portfolio Table 98. UBC Recent Development Table 99. SanaClis Company Information Table 100. SanaClis Business Overview Table 101. SanaClis Biopharmaceutical CRO Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. SanaClis Biopharmaceutical CRO Product Portfolio Table 103. SanaClis Recent Development Table 104. TFS HealthScience Company Information Table 105. TFS HealthScience Business Overview Table 106. TFS HealthScience Biopharmaceutical CRO Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. TFS HealthScience Biopharmaceutical CRO Product Portfolio Table 108. TFS HealthScience Recent Development Table 109. Parexel Company Information Table 110. Parexel Business Overview Table 111. Parexel Biopharmaceutical CRO Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Parexel Biopharmaceutical CRO Product Portfolio Table 113. Parexel Recent Development Table 114. North America Biopharmaceutical CRO Revenue by Type (2021-2026) & (US$ Million) Table 115. North America Biopharmaceutical CRO Revenue by Type (2027-2032) & (US$ Million) Table 116. North America Biopharmaceutical CRO Revenue by Application (2021-2026) & (US$ Million) Table 117. North America Biopharmaceutical CRO Revenue by Application (2027-2032) & (US$ Million) Table 118. North America Biopharmaceutical CRO Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. North America Biopharmaceutical CRO Revenue by Country (2021-2026) & (US$ Million) Table 120. North America Biopharmaceutical CRO Revenue by Country (US$ Million) & (2027-2032) Table 121. Europe Biopharmaceutical CRO Revenue by Type (2021-2026) & (US$ Million) Table 122. Europe Biopharmaceutical CRO Revenue by Type (2027-2032) & (US$ Million) Table 123. Europe Biopharmaceutical CRO Revenue by Application (2021-2026) & (US$ Million) Table 124. Europe Biopharmaceutical CRO Revenue by Application (2027-2032) & (US$ Million) Table 125. Europe Biopharmaceutical CRO Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. Europe Biopharmaceutical CRO Revenue by Country (2021-2026) & (US$ Million) Table 127. Europe Biopharmaceutical CRO Revenue by Country (US$ Million) & (2027-2032) Table 128. China Biopharmaceutical CRO Revenue by Type (2021-2026) & (US$ Million) Table 129. China Biopharmaceutical CRO Revenue by Type (2027-2032) & (US$ Million) Table 130. China Biopharmaceutical CRO Revenue by Application (2021-2026) & (US$ Million) Table 131. China Biopharmaceutical CRO Revenue by Application (2027-2032) & (US$ Million) Table 132. Asia Biopharmaceutical CRO Revenue by Type (2021-2026) & (US$ Million) Table 133. Asia Biopharmaceutical CRO Revenue by Type (2027-2032) & (US$ Million) Table 134. Asia Biopharmaceutical CRO Revenue by Application (2021-2026) & (US$ Million) Table 135. Asia Biopharmaceutical CRO Revenue by Application (2027-2032) & (US$ Million) Table 136. Asia Biopharmaceutical CRO Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Asia Biopharmaceutical CRO Revenue by Region (US$ Million) & (2021-2026) Table 138. Asia Biopharmaceutical CRO Revenue by Region (US$ Million) & (2027-2032) Table 139. SAMEA Biopharmaceutical CRO Revenue by Type (2021-2026) & (US$ Million) Table 140. SAMEA Biopharmaceutical CRO Revenue by Type (2027-2032) & (US$ Million) Table 141. SAMEA Biopharmaceutical CRO Revenue by Application (2021-2026) & (US$ Million) Table 142. SAMEA Biopharmaceutical CRO Revenue by Application (2027-2032) & (US$ Million) Table 143. SAMEA Biopharmaceutical CRO Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. SAMEA Biopharmaceutical CRO Revenue by Country (2021-2026) & (US$ Million) Table 145. SAMEA Biopharmaceutical CRO Revenue by Country (US$ Million) & (2027-2032) Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Biopharmaceutical CRO Image Figure 2. Global Biopharmaceutical CRO Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biopharmaceutical CRO Market Size Share 2021 VS 2025 VS 2032 Figure 4. Full-service CRO Image Figure 5. Specialized CRO Image Figure 6. Global Biopharmaceutical CRO Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Biopharmaceutical CRO Market Size Share 2021 VS 2025 VS 2032 Figure 8. SMBs Image Figure 9. Large Enterprises Image Figure 10. Global Biopharmaceutical CRO Market Size (US$ Million) & (2021-2032) Figure 11. Global Biopharmaceutical CRO Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Biopharmaceutical CRO Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Biopharmaceutical CRO Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Biopharmaceutical CRO Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Biopharmaceutical CRO Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Biopharmaceutical CRO Revenue Market Share by Type (2021-2032) Figure 18. Global Biopharmaceutical CRO Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Biopharmaceutical CRO Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Biopharmaceutical CRO Revenue Market Share by Application (2021-2032) Figure 21. North America Biopharmaceutical CRO Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Biopharmaceutical CRO Revenue Share by Type (2021-2032) Figure 23. North America Biopharmaceutical CRO Revenue Share by Application (2021-2032) Figure 24. North America Biopharmaceutical CRO Revenue Share by Country (2021-2032) Figure 25. United States Biopharmaceutical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Biopharmaceutical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Biopharmaceutical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Biopharmaceutical CRO Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Biopharmaceutical CRO Revenue Share by Type (2021-2032) Figure 30. Europe Biopharmaceutical CRO Revenue Share by Application (2021-2032) Figure 31. Europe Biopharmaceutical CRO Revenue Share by Country (2021-2032) Figure 32. Germany Biopharmaceutical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Biopharmaceutical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Biopharmaceutical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Biopharmaceutical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Biopharmaceutical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Biopharmaceutical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Biopharmaceutical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Biopharmaceutical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Biopharmaceutical CRO Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Biopharmaceutical CRO Revenue Share by Type (2021-2032) Figure 42. China Biopharmaceutical CRO Revenue Share by Application (2021-2032) Figure 43. Asia Biopharmaceutical CRO Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Biopharmaceutical CRO Revenue Share by Type (2021-2032) Figure 45. Asia Biopharmaceutical CRO Revenue Share by Application (2021-2032) Figure 46. Asia Biopharmaceutical CRO Revenue Share by Region (2021-2032) Figure 47. Japan Biopharmaceutical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Biopharmaceutical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Biopharmaceutical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Biopharmaceutical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Biopharmaceutical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Biopharmaceutical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Biopharmaceutical CRO Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Biopharmaceutical CRO Revenue Share by Type (2021-2032) Figure 55. SAMEA Biopharmaceutical CRO Revenue Share by Application (2021-2032) Figure 56. SAMEA Biopharmaceutical CRO Revenue Share by Country (2021-2032) Figure 57. Brazil Biopharmaceutical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Biopharmaceutical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Biopharmaceutical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Biopharmaceutical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Biopharmaceutical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Biopharmaceutical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Biopharmaceutical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Biopharmaceutical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Biopharmaceutical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Biopharmaceutical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Biopharmaceutical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Full-service CRO
  • Specialized CRO
Applications
  • SMBs
  • Large Enterprises
Companies covered
  • WuXi AppTec
  • WuXi Biologics
  • Hangzhou Tigermed
  • Pharmaron Beijing
  • ICON
  • PPD
  • BioPharma Services
  • TriStar Technology Group
  • Fortrea
  • Eurofins BioPharma Services
  • Medicilon
  • Asymchem
  • UBC
  • SanaClis
  • TFS HealthScience
  • Parexel

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Biopharmaceutical CRO Market by Type
  3. 1.2.1 Global Biopharmaceutical CRO Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Full-service CRO
  5. 1.2.3 Specialized CRO
  6. 1.3 Biopharmaceutical CRO Market by Application
  7. 1.3.1 Global Biopharmaceutical CRO Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 SMBs
  9. 1.3.3 Large Enterprises
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Biopharmaceutical CRO Market Dynamics
  1. 2.1 Biopharmaceutical CRO Industry Trends
  2. 2.2 Biopharmaceutical CRO Industry Drivers
  3. 2.3 Biopharmaceutical CRO Industry Opportunities and Challenges
  4. 2.4 Biopharmaceutical CRO Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Biopharmaceutical CRO Market Perspective (2021-2032)
  2. 3.2 Global Biopharmaceutical CRO Growth Trends by Region
  3. 3.2.1 Global Biopharmaceutical CRO Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Biopharmaceutical CRO Market Size by Region (2021-2026)
  5. 3.2.3 Global Biopharmaceutical CRO Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Biopharmaceutical CRO Revenue by Players
  2. 4.1.1 Global Biopharmaceutical CRO Revenue by Players (2021-2026)
  3. 4.1.2 Global Biopharmaceutical CRO Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Biopharmaceutical CRO Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Biopharmaceutical CRO Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Biopharmaceutical CRO Key Players Headquarters & Area Served
  7. 4.4 Global Biopharmaceutical CRO Players, Product Type & Application
  8. 4.5 Global Biopharmaceutical CRO Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Biopharmaceutical CRO Market CR5 and HHI
  11. 4.6.3 2025 Biopharmaceutical CRO Tier 1, Tier 2, and Tier 3
5 Biopharmaceutical CRO Market Size by Type
  1. 5.1 Global Biopharmaceutical CRO Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Biopharmaceutical CRO Revenue by Type (2021-2032)
  3. 5.3 Global Biopharmaceutical CRO Revenue Market Share by Type (2021-2032)
6 Biopharmaceutical CRO Market Size by Application
  1. 6.1 Global Biopharmaceutical CRO Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Biopharmaceutical CRO Revenue by Application (2021-2032)
  3. 6.3 Global Biopharmaceutical CRO Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 WuXi AppTec
  2. 7.1.1 WuXi AppTec Company Information
  3. 7.1.2 WuXi AppTec Business Overview
  4. 7.1.3 WuXi AppTec Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  5. 7.1.4 WuXi AppTec Biopharmaceutical CRO Product Portfolio
  6. 7.1.5 WuXi AppTec Recent Developments
  7. 7.2 WuXi Biologics
  8. 7.2.1 WuXi Biologics Company Information
  9. 7.2.2 WuXi Biologics Business Overview
  10. 7.2.3 WuXi Biologics Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  11. 7.2.4 WuXi Biologics Biopharmaceutical CRO Product Portfolio
  12. 7.2.5 WuXi Biologics Recent Developments
  13. 7.3 Hangzhou Tigermed
  14. 7.3.1 Hangzhou Tigermed Company Information
  15. 7.3.2 Hangzhou Tigermed Business Overview
  16. 7.3.3 Hangzhou Tigermed Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Hangzhou Tigermed Biopharmaceutical CRO Product Portfolio
  18. 7.3.5 Hangzhou Tigermed Recent Developments
  19. 7.4 Pharmaron Beijing
  20. 7.4.1 Pharmaron Beijing Company Information
  21. 7.4.2 Pharmaron Beijing Business Overview
  22. 7.4.3 Pharmaron Beijing Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Pharmaron Beijing Biopharmaceutical CRO Product Portfolio
  24. 7.4.5 Pharmaron Beijing Recent Developments
  25. 7.5 ICON
  26. 7.5.1 ICON Company Information
  27. 7.5.2 ICON Business Overview
  28. 7.5.3 ICON Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  29. 7.5.4 ICON Biopharmaceutical CRO Product Portfolio
  30. 7.5.5 ICON Recent Developments
  31. 7.6 PPD
  32. 7.6.1 PPD Company Information
  33. 7.6.2 PPD Business Overview
  34. 7.6.3 PPD Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  35. 7.6.4 PPD Biopharmaceutical CRO Product Portfolio
  36. 7.6.5 PPD Recent Developments
  37. 7.7 BioPharma Services
  38. 7.7.1 BioPharma Services Company Information
  39. 7.7.2 BioPharma Services Business Overview
  40. 7.7.3 BioPharma Services Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  41. 7.7.4 BioPharma Services Biopharmaceutical CRO Product Portfolio
  42. 7.7.5 BioPharma Services Recent Developments
  43. 7.8 TriStar Technology Group
  44. 7.8.1 TriStar Technology Group Company Information
  45. 7.8.2 TriStar Technology Group Business Overview
  46. 7.8.3 TriStar Technology Group Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  47. 7.8.4 TriStar Technology Group Biopharmaceutical CRO Product Portfolio
  48. 7.8.5 TriStar Technology Group Recent Developments
  49. 7.9 Fortrea
  50. 7.9.1 Fortrea Company Information
  51. 7.9.2 Fortrea Business Overview
  52. 7.9.3 Fortrea Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Fortrea Biopharmaceutical CRO Product Portfolio
  54. 7.9.5 Fortrea Recent Developments
  55. 7.10 Eurofins BioPharma Services
  56. 7.10.1 Eurofins BioPharma Services Company Information
  57. 7.10.2 Eurofins BioPharma Services Business Overview
  58. 7.10.3 Eurofins BioPharma Services Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Eurofins BioPharma Services Biopharmaceutical CRO Product Portfolio
  60. 7.10.5 Eurofins BioPharma Services Recent Developments
  61. 7.11 Medicilon
  62. 7.11.1 Medicilon Company Information
  63. 7.11.2 Medicilon Business Overview
  64. 7.11.3 Medicilon Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Medicilon Biopharmaceutical CRO Product Portfolio
  66. 7.11.5 Medicilon Recent Developments
  67. 7.12 Asymchem
  68. 7.12.1 Asymchem Company Information
  69. 7.12.2 Asymchem Business Overview
  70. 7.12.3 Asymchem Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Asymchem Biopharmaceutical CRO Product Portfolio
  72. 7.12.5 Asymchem Recent Developments
  73. 7.13 UBC
  74. 7.13.1 UBC Company Information
  75. 7.13.2 UBC Business Overview
  76. 7.13.3 UBC Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  77. 7.13.4 UBC Biopharmaceutical CRO Product Portfolio
  78. 7.13.5 UBC Recent Developments
  79. 7.14 SanaClis
  80. 7.14.1 SanaClis Company Information
  81. 7.14.2 SanaClis Business Overview
  82. 7.14.3 SanaClis Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  83. 7.14.4 SanaClis Biopharmaceutical CRO Product Portfolio
  84. 7.14.5 SanaClis Recent Developments
  85. 7.15 TFS HealthScience
  86. 7.15.1 TFS HealthScience Company Information
  87. 7.15.2 TFS HealthScience Business Overview
  88. 7.15.3 TFS HealthScience Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  89. 7.15.4 TFS HealthScience Biopharmaceutical CRO Product Portfolio
  90. 7.15.5 TFS HealthScience Recent Developments
  91. 7.16 Parexel
  92. 7.16.1 Parexel Company Information
  93. 7.16.2 Parexel Business Overview
  94. 7.16.3 Parexel Biopharmaceutical CRO Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Parexel Biopharmaceutical CRO Product Portfolio
  96. 7.16.5 Parexel Recent Developments
8 North America
  1. 8.1 North America Biopharmaceutical CRO Revenue (2021-2032)
  2. 8.2 North America Biopharmaceutical CRO Revenue by Type (2021-2032)
  3. 8.2.1 North America Biopharmaceutical CRO Revenue by Type (2021-2026)
  4. 8.2.2 North America Biopharmaceutical CRO Revenue by Type (2027-2032)
  5. 8.3 North America Biopharmaceutical CRO Revenue Share by Type (2021-2032)
  6. 8.4 North America Biopharmaceutical CRO Revenue by Application (2021-2032)
  7. 8.4.1 North America Biopharmaceutical CRO Revenue by Application (2021-2026)
  8. 8.4.2 North America Biopharmaceutical CRO Revenue by Application (2027-2032)
  9. 8.5 North America Biopharmaceutical CRO Revenue Share by Application (2021-2032)
  10. 8.6 North America Biopharmaceutical CRO Revenue by Country
  11. 8.6.1 North America Biopharmaceutical CRO Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Biopharmaceutical CRO Revenue by Country (2021-2026)
  13. 8.6.3 North America Biopharmaceutical CRO Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Biopharmaceutical CRO Revenue (2021-2032)
  2. 9.2 Europe Biopharmaceutical CRO Revenue by Type (2021-2032)
  3. 9.2.1 Europe Biopharmaceutical CRO Revenue by Type (2021-2026)
  4. 9.2.2 Europe Biopharmaceutical CRO Revenue by Type (2027-2032)
  5. 9.3 Europe Biopharmaceutical CRO Revenue Share by Type (2021-2032)
  6. 9.4 Europe Biopharmaceutical CRO Revenue by Application (2021-2032)
  7. 9.4.1 Europe Biopharmaceutical CRO Revenue by Application (2021-2026)
  8. 9.4.2 Europe Biopharmaceutical CRO Revenue by Application (2027-2032)
  9. 9.5 Europe Biopharmaceutical CRO Revenue Share by Application (2021-2032)
  10. 9.6 Europe Biopharmaceutical CRO Revenue by Country
  11. 9.6.1 Europe Biopharmaceutical CRO Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Biopharmaceutical CRO Revenue by Country (2021-2026)
  13. 9.6.3 Europe Biopharmaceutical CRO Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Biopharmaceutical CRO Revenue (2021-2032)
  2. 10.2 China Biopharmaceutical CRO Revenue by Type (2021-2032)
  3. 10.2.1 China Biopharmaceutical CRO Revenue by Type (2021-2026)
  4. 10.2.2 China Biopharmaceutical CRO Revenue by Type (2027-2032)
  5. 10.3 China Biopharmaceutical CRO Revenue Share by Type (2021-2032)
  6. 10.4 China Biopharmaceutical CRO Revenue by Application (2021-2032)
  7. 10.4.1 China Biopharmaceutical CRO Revenue by Application (2021-2026)
  8. 10.4.2 China Biopharmaceutical CRO Revenue by Application (2027-2032)
  9. 10.5 China Biopharmaceutical CRO Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Biopharmaceutical CRO Revenue (2021-2032)
  2. 11.2 Asia Biopharmaceutical CRO Revenue by Type (2021-2032)
  3. 11.2.1 Asia Biopharmaceutical CRO Revenue by Type (2021-2026)
  4. 11.2.2 Asia Biopharmaceutical CRO Revenue by Type (2027-2032)
  5. 11.3 Asia Biopharmaceutical CRO Revenue Share by Type (2021-2032)
  6. 11.4 Asia Biopharmaceutical CRO Revenue by Application (2021-2032)
  7. 11.4.1 Asia Biopharmaceutical CRO Revenue by Application (2021-2026)
  8. 11.4.2 Asia Biopharmaceutical CRO Revenue by Application (2027-2032)
  9. 11.5 Asia Biopharmaceutical CRO Revenue Share by Application (2021-2032)
  10. 11.6 Asia Biopharmaceutical CRO Revenue by Country
  11. 11.6.1 Asia Biopharmaceutical CRO Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Biopharmaceutical CRO Revenue by Country (2021-2026)
  13. 11.6.3 Asia Biopharmaceutical CRO Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Biopharmaceutical CRO Revenue (2021-2032)
  2. 12.2 SAMEA Biopharmaceutical CRO Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Biopharmaceutical CRO Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Biopharmaceutical CRO Revenue by Type (2027-2032)
  5. 12.3 SAMEA Biopharmaceutical CRO Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Biopharmaceutical CRO Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Biopharmaceutical CRO Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Biopharmaceutical CRO Revenue by Application (2027-2032)
  9. 12.5 SAMEA Biopharmaceutical CRO Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Biopharmaceutical CRO Revenue by Country
  11. 12.6.1 SAMEA Biopharmaceutical CRO Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Biopharmaceutical CRO Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Biopharmaceutical CRO Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst